Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀÌ¿ÂÈ­ ¹æ»ç¼±¿¡ ÀÇÇÑ TIMP1, TIMP2 À¯ÀüÀÚ ¹ßÇö ÃøÁ¤ Expression of TIMP1, TIMP2 Genes by lonizing Radiation

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 2001³â 19±Ç 2È£ p.171 ~ 180
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú°Ç±¸/Kun-Koo Park ÁøÁ¤¼±/¹Ú±â¿µ/ÀÌ¿¬Èñ/±è»óÀ±/³ë¿µÁÖ/¾È½Âµµ/±èÁ¾ÈÆ/ÃÖÀº°æ/ÀåÇý¼÷/Jung Sun Jin/Ki Yong Park/Yun Hee Lee/Sang Yoon Kim/Young Ju Noh/Seung Do Ahn/Jong Hoon Kim/Eun Kyung Choi/Hyesook Chang

Abstract

¸ñÀû: Tissue inhibitor of matrix metalloproteinase (TMP)´Â matrix metalloproteinase (MMP)¿¡ ÀÛ¿ëÇÏ¿© ¾Ï¼¼Æ÷ÀÇ Ä§À±°ú ÀüÀ̸¦ ¾ïÁ¦ÇÏ°í ¿°Áõ, angiogenesis, fibrosis¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. TIMP À¯ÀüÀÚ´Â ¿©·¯ cytokine ¹× signal molecule¿¡ ÀÇÇÏ¿©
Á¶ÀýµÇ´Â
À¯ÀüÀÚÀ̹ǷΠ¹æ»ç¼±¿¡ ÀÇÇÑ TIMPÀÇ ¹ßÇöÀ» ÃøÁ¤ÇÏ°í Àü»ç Á¶Àý ±âÀüÀ» ¿¬±¸ÇÏ°íÀÚ ÇÏ¿´´Ù.
´ë»ó ¹× ¹æ¹ý: µÎ°æºÎ¾Ï ȯÀÚÀÇ º´º¯¿¡¼­ À¯µµÇÏ¿© È®¸³ÇÑ µÎ°æºÎ¾Ï ¼¼Æ÷ÁÖ¸¦ ÀÌ¿ëÇÏ¿© ¹æ
»ç¼±¿¡ ÀÇÇÑ TIMP À¯ÀüÀÚ ¹ßÇöÀ» ÃøÁ¤ÇÏ¿´´Ù. °¢ ¼¼Æ÷ÁÖÀÇ ¹æ»ç¼± ¹Î°¨µµ¸¦ ÃøÁ¤ÇÏ°í
transwellÀ» ÀÌ¿ëÇÑ invasion assay·Î ÀüÀ̼ºÀ» ÃøÁ¤ÇÏ¿´´Ù. TIMP1, TIMP2 ¹ßÇöÀº
conditioned mediumÀ» ÃëÇØ ELISA assay·Î ÃøÁ¤ÇÏ¿´´Ù. ¹æ»ç¼±Á¶»ç´Â 2Gy , 10Gy ±ºÀ¸·Î
³ª´©¾î °üÂûÇß°í Á¶»ç ÈÄ ½Ã°£ °£°ÝÀº 24, 48½Ã°£À̾ú´Ù. MTT assay·Î »ýÁ¸¼¼Æ÷ ¼ö¸¦ Ãø
Á¤ÇÏ¿© ¹æ»ç¼± ¼¼Æ÷Ä¡»ç·Î ÀÎÇÑ ¹ßÇö º¯È­¸¦ º¸Á¤ÇÏ¿´´Ù. hTMP1 promoter regionÀ» PCR
ÇÏ¿© pGL2-basic luciferase reporter vector¿¡ cloningÇÏ¿© Àΰ£ µÎ°æºÎ¾Ï ¼¼Æ÷ÁÖ¿¡ ÀÌÀÔÇÏ
¿© functional TIMP1 ¹ßÇöÀÌ Áõ°¡ÇÏ´ÂÁö È®ÀÎÇÏ¿´°í protein kinase C (PKC) activatorÀÎ
PMA (phorbol 12-myristate 13-acetate)¿Í Ras¿¡ ÀÇÇÑ TIMP1¹ßÇöÀÌ À¯µµµÇ´ÂÁö È®ÀÎÇÏ¿´
´Ù.
°á°ú: HN-1, HN-2, HN-3, HN-5, HN-9 ¼¼Æ÷ÁÖÀÇ D0´Â °¢°¢ 1.55 Gy, 1.8
Gy, 1.5 Gy, 1.55 Gy, 2.45Gy À̾ú´Ù. °¢ ¼¼Æ÷ÁÖÀÇ ¹æ»ç¼±Á¶»ç ÈÄ MTT assay¿¡ ÀÇÇÑ cell
viability´Â 24, 48½Ã°£¿¡¼­ 2 GyÀÎ °æ¿ì ¸ðµÎ 94% ÀÌ»ó ±×¸®°í 10 Gy¿¡¼­´Â 73% ÀÌ»óÀÇ
»ýÁ¸ ¼¼Æ÷¸¦ È®ÀÎÇÏ¿´´Ù. TIMP1, TIMP2 ´Ü¹éÀÇ basal ³óµµ´Â 24½Ã°£ 48½Ã°£¿¡¼­ Á¡Á¡ Áõ
°¡ÇÏ¿© ¼¼Æ÷¿¡¼­ °è¼Ó ÇÕ¼ºµÇ¾î ºÐºñµÇ°í ÀÖÀ½À» È®ÀÎÇÏ¿´´Ù. 2 GyÁ¶»ç ÈÄ 24½Ã°£¿¡¼­
TIMP2´Â HN-1, HN-9 ¼¼Æ÷ÁÖ¿¡¼­ °¨¼ÒÇÏ¿´À¸³ª, 10 Gy Á¶»ç ÈÄ¿¡´Â µÎ ¼¼Æ÷ÁÖ¿¡¼­ ¸ðµÎ
Áõ°¡ÇÏ¿© ¹æ»ç¼±·®¿¡ µû¶ó ¹ÝÀÀÀÌ ´Þ¶ú°í, ¹æ»ç¼±Á¶»çÈÄ 48½Ã°£¿¡´Â HN-1¼¼Æ÷ÁÖ¿¡¼­´Â Áõ
°¡Çϳª HN-9 ¼¼Æ÷ÁÖ¿¡¼­´Â °¨¼ÒÇÏ¿© ¼¼Æ÷ÁÖ¿¡ µû¶ó ¹ÝÀÀÀÌ ´Þ¶ú´Ù. ±×·¯³ª ¹æ»ç¼±¿¡ ÀÇÇÑ
TIMP1 ¹ßÇö º¯È­´Â ¹Ì¹ÌÇÏ¿´´Ù. TIMP1 reporter geneÀ» Àΰ£ µÎ°æºÎ¾Ï ¼¼Æ÷ÁÖ¿¡
transfectionÇÏ°í PMA(100 ng/ml)À» °¡ÇÑ °æ¿ì HN-1¼¼Æ÷ÁÖ¿¡¼­´Â À¯ÀÇÇÏ°Ô Áõ°¡ÇÏ°í
HN-9 ¼¼Æ÷ÁÖ¿¡¼­´Â °¨¼ÒÇÏ¿´´Ù. Ras ¹ßÇö ¹éÅÍ¿Í co-transfectionÇÑ °æ¿ì TIMP1 promoter
°¡ È°¼ºÈ­ µÇ¾ú´Ù.
°á·Ð: ¸ðµÎ µÎ°æºÎ ¾Ï¿¡¼­ À¯·¡µÈ ¼¼Æ÷ÁÖ ÀÌÁö¸¸ ¹æ»ç¼±¿¡ ÀÇÇÑ TIMPÀÇ ¹ßÇö ¹× Àü»çÁ¶Àý
±âÀüÀº ¼¼Æ÷ÁÖ ¸¶´Ù Â÷ÀÌ°¡ ÀÖ¾ú°í ÀÌ¿ÂÈ­ ¹æ»ç¼±ÀÇ¿ë·®¿¡ µû¶ó¼­, ¹æ»ç¼±Á¶»ç ÈÄÀÇ ½Ã°£
°æ°ú¿¡ µû¶ó¼­µµ TIMP ¹ßÇö¿¡ Â÷ÀÌ°¡ À̾ú´Ù. ÀÌ °á°ú´Â TIMPÀÇ Àü»ç ¹× ¹ßÇöÀÌ ¿©·¯ Á¾
·ùÀÇ signal molecule¿¡ ÀÇÇÏ¿© ¿µÇâÀ» ¹Þ°í, ÀÌ signal moleculeµéÀÌ °¢ ¼¼Æ÷ÁÖ ¸¶´Ù ´Ù¸£
±â ¶§¹®À¸·Î »ç·áµÈ´Ù.

Purpose: Expression of TIMP, intrinsic inhibitor of MMP, is regulated by signal transduction in response to genotoxins and is likely to be an important step in metastasis, angiogenesis and wound healing after ionizing radiation. Therefore, we
studied
radiation mediated TMP expression and its mechanism in head and neck cancer cell lines.
Materials and Methods: Human head and neck cancer cell lines established at Asan
Medical Center were used and radiosensitivity (D0), radiation cytotoxicity
and metastatic potential were measured by clonogenic assay, MTT assay and invasion
assay, respectively. The conditioned medium was prepared at 24 hours and 48 hours
after 2 Gy and 10 Gy irradiation and expression of TIMP protein was measured by
Elisa assay with specific antibodies against human TIMP. hTIMP1 promotor region was
cloned and TIMP1 luciferase reporter vector was constructed. The reporter vector was
transfected to AMC-HN-1 and -HN-9 cells with or without expression vector Ras, then
the cells were exposed to radiation or PMA, PKC activator. EMSA was performed with
oligonucleotide (-59/-53 element and SP1) of TIMP1 promotor.
Results: D0 of HN-1, -2, -3, -5 and -9 cell lines were 1.55 Gy, 1.8 Gy,
1.5 Gt, 1.55 Gy and 2.45 Gy respectively. MTT assay confirmed cell viability, over 94%
at 24hrs, 48hrs after 2 Gy irradiation and over 73% after 10 Gy irradiation. Elisa assay
confirmed that cells secreted TIMP1, 2 proteins continuously. After 2 Gy irradiation,
TIMP2 secretion was decreased at 24hrs in HN-1 and HN-9 cell lines but after 10 Gy
irradiation, it was increase in all cell lines. At 48hrs after irradiation, it was increased in
HN-1 but decreased in HN-9 cells. But the change in TIMP secretion by RT was mild.
The transcription of TIMP1 gene in HN-1 was induced by PMA but in HN-9 cell lines,
it was suppressed. Wild type Ras induced the TIMP-1 transcription by 20 fold and 4
fold in HN-1 and HN-9 respectively. The binding activity to -59/-53, AP1 motif was
increased by RT, but not to SP1 motif in both cell lines.
Conclusions: We observed the difference of expression and activity of TIMPs between
radiosensitive and radioresistant cell line and the different signal transduction pathway
between in these cell lines may contribute the different radiosensitivity. Further research
to investigate the radiation response and its signal pathway of TIMPs is needed

Å°¿öµå

TIMP; Gene regulation; µÎ°æºÎ¾Ï; ¹æ»ç¼±; TIMP; Gene regulation; Head and neck cancer; Radiation;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS